Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,386,797
-$320,439 QoQ
Shares Held
24,068
-14.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#992
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names. BMY ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
|
2,086 | $326,917 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,386,797 | 24,068 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,707,236 | 28,149 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,533,243 | 28,425 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,235,694 | 27,399 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,375,646 | 29,718 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,892,031 | 31,022 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,733,845 | 30,655 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,507,030 | 29,127 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,591,263 | 38,316 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,220,067 | 40,938 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $1,913,041 | 37,284 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,097,680 | 36,142 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,371,329 | 37,081 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,542,636 | 36,685 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,709,852 | 37,663 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,469,168 | 34,733 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,812,425 | 36,525 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,617,321 | 35,839 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,265,549 | 36,336 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,202,366 | 37,221 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,517,643 | 37,678 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $2,462,763 | 39,011 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $2,443,981 | 39,400 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $2,446,447 | 40,578 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $2,358,938 | 40,118 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $3,125,509 | 56,073 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||